Search for: "WYETH PHARMACEUTICALS, INC."
Results 301 - 320
of 515
Sort by Relevance
|
Sort by Date
27 May 2010, 3:20 am
Anchen Pharmaceuticals Inc et al. [read post]
25 May 2010, 12:51 pm
Wyeth, Inc. [read post]
13 May 2010, 4:58 pm
Watson Pharmaceuticals Inc. et al. [read post]
13 May 2010, 12:27 pm
Wyeth, Inc., 2010 WL 450351 (W.D. [read post]
11 May 2010, 9:06 pm
Robins, Inc., and American Home Products Corporation, and Schwarz Pharma, Inc. [read post]
6 May 2010, 4:12 pm
Novartis Pharmaceuticals Corp., 564 F. [read post]
6 May 2010, 9:43 am
Wyeth, Inc., 601 F.Supp.2d 1262 (W.D.Okla. 2009), which was decided 5 days before Stacel. [read post]
5 May 2010, 4:46 am
Cyclacel Pharmaceuticals Inc. [read post]
2 May 2010, 9:52 pm
Watson Pharmaceuticals, Inc. et al. 0:10-cv-60674; filed April 29, 2010 in the Southern District of Florida • Plaintiffs: Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc. [read post]
1 May 2010, 9:45 am
Robins, Inc., and American Home Products Corporation, and Schwarz Pharma, Inc. [read post]
27 Apr 2010, 10:58 pm
(The SPC Blog) EU: Originator drug companies hit by European ruling: C-62/09 Association of the British Pharmaceutical Industry (Managing Intellectual Property) EU: EPO – Convention on Biological Diversity and the exception to patentability for inventions which are contrary to ‘ordre public’ or morality (EPLAW) India: Patent office releases details on pharmaceutical product patents granted in last 3 years (Generic Pharmaceuticals and IP) (Spicy IP) Kenya:… [read post]
27 Apr 2010, 4:30 am
For example, when the Court found no implied preemption in the pharmaceutical labeling case, Wyeth v. [read post]
21 Apr 2010, 12:08 pm
Wyeth Inc., 2008 WL 2856146 (N.J. [read post]
1 Apr 2010, 1:42 pm
Novartis Pharmaceuticals Corp., 2000 WL 33915848 (E.D. [read post]
22 Mar 2010, 4:30 am
Centocor, Inc. v. [read post]
15 Mar 2010, 2:09 pm
BIC USA, Inc., 136 F.Supp.2d 196, 207-208 (S.D.N.Y. 2000) (Consumer Product Safety Commission) (“The CPSC regulations establish general, rudimentary and minimal requirements. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
4 Mar 2010, 10:58 am
DJO Inc., 663 F. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
